+

NO20065905L - Ny assosiasjon av en sinusknute If strominhibitor og en angiotensinkonvertaseinhibitor, og farmasoytiske sammensetninger inneholdende den - Google Patents

Ny assosiasjon av en sinusknute If strominhibitor og en angiotensinkonvertaseinhibitor, og farmasoytiske sammensetninger inneholdende den

Info

Publication number
NO20065905L
NO20065905L NO20065905A NO20065905A NO20065905L NO 20065905 L NO20065905 L NO 20065905L NO 20065905 A NO20065905 A NO 20065905A NO 20065905 A NO20065905 A NO 20065905A NO 20065905 L NO20065905 L NO 20065905L
Authority
NO
Norway
Prior art keywords
inhibitor
pharmaceutical compositions
compositions containing
sinus node
new association
Prior art date
Application number
NO20065905A
Other languages
English (en)
Other versions
NO337640B1 (no
Inventor
Vidal Benatar
Guy Lerebours-Pigeonniere
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36685870&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20065905(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20065905L publication Critical patent/NO20065905L/no
Publication of NO337640B1 publication Critical patent/NO337640B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)

Abstract

Assosiasjon omfattende en selektiv og spesifikk sinusknute-If-strøminhibitor, mer spesielt ivabradin, og et middel som hemmer angiotensinkonvertase.
NO20065905A 2005-12-21 2006-12-19 Ny assosiasjon av en sinusknute If strøminhibitor og en angiotensinkonvertaseinhibitor, og farmasøytiske sammensetninger inneholdende den NO337640B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0513006A FR2894825B1 (fr) 2005-12-21 2005-12-21 Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent

Publications (2)

Publication Number Publication Date
NO20065905L true NO20065905L (no) 2007-06-22
NO337640B1 NO337640B1 (no) 2016-05-23

Family

ID=36685870

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065905A NO337640B1 (no) 2005-12-21 2006-12-19 Ny assosiasjon av en sinusknute If strøminhibitor og en angiotensinkonvertaseinhibitor, og farmasøytiske sammensetninger inneholdende den

Country Status (41)

Country Link
US (2) US20070142355A1 (no)
EP (2) EP2298297A1 (no)
JP (2) JP4705564B2 (no)
KR (2) KR100907583B1 (no)
CN (1) CN101015557B (no)
AP (1) AP2119A (no)
AR (1) AR058574A1 (no)
AT (1) ATE508742T1 (no)
AU (1) AU2006252210B2 (no)
BR (1) BRPI0605517A (no)
CA (1) CA2571644C (no)
CO (1) CO5790168A1 (no)
CR (1) CR8820A (no)
CY (1) CY1111575T1 (no)
DK (1) DK1800678T3 (no)
EA (1) EA011253B1 (no)
ES (1) ES2366570T3 (no)
FR (1) FR2894825B1 (no)
GE (1) GEP20094604B (no)
GT (1) GT200600522A (no)
HR (1) HRP20110532T1 (no)
IL (1) IL180204A (no)
JO (1) JO2699B1 (no)
MA (1) MA28723B1 (no)
ME (1) ME01958B (no)
MX (1) MXPA06014885A (no)
MY (1) MY146956A (no)
NO (1) NO337640B1 (no)
NZ (1) NZ552221A (no)
PE (2) PE20071004A1 (no)
PL (1) PL1800678T3 (no)
PT (1) PT1800678E (no)
RS (1) RS51731B (no)
SA (1) SA06270480B1 (no)
SG (2) SG133545A1 (no)
SI (1) SI1800678T1 (no)
TW (1) TWI369206B (no)
UA (1) UA86417C2 (no)
UY (1) UY30023A1 (no)
WO (1) WO2007077327A1 (no)
ZA (1) ZA200610824B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2920772B1 (fr) * 2007-09-11 2009-10-23 Servier Lab Association entre un anti-atherothrombotique et un inhibiteur de l'enzyme de conversion de l'angiotensine
FR2927538B1 (fr) * 2008-02-14 2010-02-19 Servier Lab Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.
CN101564394B (zh) * 2008-04-21 2010-12-15 鲁南制药集团股份有限公司 含有伊伐布雷定和曲美他嗪的药物组合物
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
WO2013116738A1 (en) * 2012-02-03 2013-08-08 Cardeus Pharmaceuticals, Inc. Drug formulations
PH12018502155B1 (en) 2016-04-20 2024-03-27 Servier Lab Pharmaceutical composition comprising a beta blocker, a converting enzyme inhibitor and an antihypertensive or an nsaid

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4508729A (en) * 1979-12-07 1985-04-02 Adir Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
DE3736866A1 (de) * 1987-10-30 1989-05-11 Thomae Gmbh Dr K Mittel zur behandlung des bluthochdrucks und der herzinsuffizienz
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
DE10018401A1 (de) * 2000-04-13 2001-10-25 Boehringer Ingelheim Pharma Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen
EP1402066A4 (en) * 2001-06-08 2008-10-22 Ortho Mcneil Pharm Inc PAIN TREATMENT WITH HYPERPOLARIZATION ACTIVATED CHANNELS CONTROLLED BY CYCLIC NUCLEOTIDE AS ATTACK POINT
AR036187A1 (es) * 2001-07-24 2004-08-18 Adir Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario
EP1426051B1 (en) * 2001-09-11 2008-07-16 Asahi Kasei Pharma Corporation Medicinal composition for prevention of or treatment for cerebrovascular disorder
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
DK1362590T3 (da) * 2002-07-25 2004-03-29 Boehringer Ingelheim Pharma Anvendelse af cilobradin eller farmaceutisk acceptable salte deraf til behandling eller forebyggelse af hjertesvigt
FR2882554B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882553B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline beta du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882555B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2882556B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme cristalline gamma d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
AP2119A (en) 2010-04-21
ME01958B (me) 2011-10-31
NZ552221A (en) 2008-05-30
PE20110116A1 (es) 2011-03-02
TWI369206B (en) 2012-08-01
US20070142355A1 (en) 2007-06-21
SG173243A1 (en) 2011-08-29
GT200600522A (es) 2007-07-25
EA011253B1 (ru) 2009-02-27
IL180204A (en) 2014-02-27
PL1800678T3 (pl) 2011-08-31
EP1800678B1 (fr) 2011-05-11
ES2366570T3 (es) 2011-10-21
CN101015557A (zh) 2007-08-15
AP2006003859A0 (en) 2006-12-31
CN101015557B (zh) 2010-12-08
ZA200610824B (en) 2008-06-25
BRPI0605517A (pt) 2007-10-16
US20120196850A1 (en) 2012-08-02
EP1800678A1 (fr) 2007-06-27
CY1111575T1 (el) 2015-10-07
UY30023A1 (es) 2007-01-31
AU2006252210A1 (en) 2007-07-05
FR2894825B1 (fr) 2010-12-03
PT1800678E (pt) 2011-07-12
EA200602155A1 (ru) 2007-08-31
JP2011079854A (ja) 2011-04-21
FR2894825A1 (fr) 2007-06-22
ATE508742T1 (de) 2011-05-15
AR058574A1 (es) 2008-02-13
KR100907583B1 (ko) 2009-07-14
IL180204A0 (en) 2008-01-20
HK1106444A1 (en) 2008-03-14
MY146956A (en) 2012-10-15
HRP20110532T1 (hr) 2011-08-31
SG133545A1 (en) 2007-07-30
GEP20094604B (en) 2009-02-10
DK1800678T3 (da) 2011-08-15
EP2298297A1 (fr) 2011-03-23
CA2571644A1 (fr) 2007-06-21
KR20090047424A (ko) 2009-05-12
JP2007169283A (ja) 2007-07-05
UA86417C2 (ru) 2009-04-27
WO2007077327A1 (fr) 2007-07-12
MA28723B1 (fr) 2007-07-02
MXPA06014885A (es) 2009-02-11
JO2699B1 (en) 2013-03-03
CA2571644C (fr) 2011-03-08
NO337640B1 (no) 2016-05-23
CR8820A (es) 2007-08-28
AU2006252210B2 (en) 2012-04-26
SA06270480B1 (ar) 2011-02-23
PE20071004A1 (es) 2007-11-17
CO5790168A1 (es) 2007-08-31
RS51731B (en) 2011-10-31
KR20070066921A (ko) 2007-06-27
JP4705564B2 (ja) 2011-06-22
TW200744608A (en) 2007-12-16
SI1800678T1 (sl) 2011-08-31

Similar Documents

Publication Publication Date Title
NO20065905L (no) Ny assosiasjon av en sinusknute If strominhibitor og en angiotensinkonvertaseinhibitor, og farmasoytiske sammensetninger inneholdende den
NO20074807L (no) Fast farmasoytisk doseringsformulering
NO20091976L (no) Nye forbindelser
ATE534383T1 (de) Zusammensetzungen aus n-ä2,4-bis(1,1- dimethylethyl)-5-hydroxyphenylü-1,4-dihydro-4- oxochinolin-3-carboxamid
NO20065903L (no) Ny assosiasjon av en sinusknute If strominhibitor og en kalsiuminhibitor, og farmasoytiske sammensetninger inneholdende den
NO20081160L (no) Benzimidazoltiofen forbindelser
TW200733954A (en) Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
ATE417915T1 (de) Reinigungsaktive und desinfizierende zusammensetzung
TW200517117A (en) Stabilized compositions containing an oxygen-labile active agent
ATE375084T1 (de) Verfahren zum töten von sporen
NO20061944L (no) Ny assosiasjon av et antiaterotrombotisk middel og et antiplateaggregerede middel
PL360523A1 (pl) Sposób aplikacji środka biocydowego, sposób obróbkSposób aplikacji środka biocydowego, sposób obróbki produktu żywnościowego, sposób aplikacji gazu bii produktu żywnościowego, sposób aplikacji gazu biocydowego, układ do aplikacji środka biocydowegoocydowego, układ do aplikacji środka biocydowego
UA99817C2 (ru) Объединение ингибитора тока if синусно-предсердного узла и бета-адреноблокатора
NO20044700L (no) Ny assoiasjon av et antitrombotisk middel og aspirin
TW200505868A (en) New synerglstic combinations
UA3515U (uk) Застосування перекису водню для профілактики сапролегніозу ікри риб
RU2003133404A (ru) Антимикробное средство
RU2008136177A (ru) Средство для лечения гемофилии
TNSN06423A1 (fr) Nouvelle association d' un inhibiteur du courant if sinusal et d' un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载